Helodormin
Helodormin is a E7Q, E8Q analog of helodermin. Helodermin is a peptide originally found in Heloderma lizards. Helodermin exhibits vasodilatory and antihypertensive activities, decreasing blood pressure in vivo; this arterial relaxation is accompanied by a decrease in intracellular Ca2+ and an increase in cAMP. Helodermin may also exhibit anticancer benefit, inhibiting cell proliferation of small cell lung cancer (SCLC) cells in vitro.
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18930404
Cas No. |
89468-62-2 |
---|---|
Purity |
≥98% |
Formula |
C176H285N47O49 |
Formula Wt. |
3843.47 |
Chemical Name |
5-L-isoleucine-8-L-glutamine-9-L-glutamine-24-L-alanine-30-L-arginine-34-de-L-arginine-36-L-prolinamide-37-de-L-serine-38-de-L-serine- Helospectin I |
Synonym |
Exendin 2; Helodermin; Heliodermin. |
Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.
Tanaka Y, Horikawa N, Ishiro H, et al. Glibenclamide-sensitive mechanism is involved in helodermin-produced vasodilatation in rat mesenteric artery. Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):141-56. PMID: 9467823.
Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 1993;52(24):PL267-71. PMID: 8389407.
Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.